Cargando…

In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum

BACKGROUND: The autonomic nervous system (ANS) maintains glucose homeostasis. While higher than normal glucose levels stimulate the ANS toward reduction, previous findings suggest an association between sensitivity to, or pain from, pressure at the chest bone (pressure or pain sensitivity, PPS) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Faber, Jens, Ballegaard, Søren, Ørsted, Nanna, Eldrup, Ebbe, Karpatschof, Benny, Gyntelberg, Finn, Hecquet, Sofie Korsgaard, Gjedde, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303981/
https://www.ncbi.nlm.nih.gov/pubmed/37389368
http://dx.doi.org/10.3389/fnins.2023.1067098
_version_ 1785065402912473088
author Faber, Jens
Ballegaard, Søren
Ørsted, Nanna
Eldrup, Ebbe
Karpatschof, Benny
Gyntelberg, Finn
Hecquet, Sofie Korsgaard
Gjedde, Albert
author_facet Faber, Jens
Ballegaard, Søren
Ørsted, Nanna
Eldrup, Ebbe
Karpatschof, Benny
Gyntelberg, Finn
Hecquet, Sofie Korsgaard
Gjedde, Albert
author_sort Faber, Jens
collection PubMed
description BACKGROUND: The autonomic nervous system (ANS) maintains glucose homeostasis. While higher than normal glucose levels stimulate the ANS toward reduction, previous findings suggest an association between sensitivity to, or pain from, pressure at the chest bone (pressure or pain sensitivity, PPS) and activity of the ANS. A recent randomized controlled trial (RCT) of type 2 diabetes (T2DM) suggested that addition of an experimental, non-pharmacological intervention more effectively than conventional treatment lowered the levels of both PPS and HbA1c. MATERIALS AND ANALYSES: We tested the null hypothesis that conventional treatment (n = 60) would reveal no association between baseline HbA1c and normalization of HbA1c in 6 months, related to change of PPS. We compared the changes of HbA1c in PPS reverters who experienced a minimum reduction of 15 units of PPS and in PPS non-reverters who experienced no reduction. Depending on the result, we tested the association in a second group of participants with addition of the experimental program (n = 52). RESULTS: In the conventional group, PPS reverters experienced normalization of HbA1c that corrected the basal increase, thus disproving the null hypothesis. With the addition of the experimental program, PPS reverters experienced similar reduction. The reduction of HbA1c among reverters averaged 0.62 mmol/mol per mmol/mol increase of baseline HbA1c (P < 0.0001 compared to non-reverters). For baseline HbA1c ≥ 64 mmol/mol, reverters averaged 22% reduction of HbA1c (P < 0.01). CONCLUSION: In consecutive analyses of two different populations of individuals with T2DM, we demonstrated that the higher the baseline HbA1c, the greater the reduction of HbA1c but only in individuals with a concomitant reduction of sensitivity to PPS, suggesting a homeostatic effect of the autonomic nervous system on glucose metabolism. As such, ANS function, measured as PPS, is an objective measure of HbA1c homeostasis. This observation may be of great clinical importance.
format Online
Article
Text
id pubmed-10303981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103039812023-06-29 In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum Faber, Jens Ballegaard, Søren Ørsted, Nanna Eldrup, Ebbe Karpatschof, Benny Gyntelberg, Finn Hecquet, Sofie Korsgaard Gjedde, Albert Front Neurosci Neuroscience BACKGROUND: The autonomic nervous system (ANS) maintains glucose homeostasis. While higher than normal glucose levels stimulate the ANS toward reduction, previous findings suggest an association between sensitivity to, or pain from, pressure at the chest bone (pressure or pain sensitivity, PPS) and activity of the ANS. A recent randomized controlled trial (RCT) of type 2 diabetes (T2DM) suggested that addition of an experimental, non-pharmacological intervention more effectively than conventional treatment lowered the levels of both PPS and HbA1c. MATERIALS AND ANALYSES: We tested the null hypothesis that conventional treatment (n = 60) would reveal no association between baseline HbA1c and normalization of HbA1c in 6 months, related to change of PPS. We compared the changes of HbA1c in PPS reverters who experienced a minimum reduction of 15 units of PPS and in PPS non-reverters who experienced no reduction. Depending on the result, we tested the association in a second group of participants with addition of the experimental program (n = 52). RESULTS: In the conventional group, PPS reverters experienced normalization of HbA1c that corrected the basal increase, thus disproving the null hypothesis. With the addition of the experimental program, PPS reverters experienced similar reduction. The reduction of HbA1c among reverters averaged 0.62 mmol/mol per mmol/mol increase of baseline HbA1c (P < 0.0001 compared to non-reverters). For baseline HbA1c ≥ 64 mmol/mol, reverters averaged 22% reduction of HbA1c (P < 0.01). CONCLUSION: In consecutive analyses of two different populations of individuals with T2DM, we demonstrated that the higher the baseline HbA1c, the greater the reduction of HbA1c but only in individuals with a concomitant reduction of sensitivity to PPS, suggesting a homeostatic effect of the autonomic nervous system on glucose metabolism. As such, ANS function, measured as PPS, is an objective measure of HbA1c homeostasis. This observation may be of great clinical importance. Frontiers Media S.A. 2023-06-14 /pmc/articles/PMC10303981/ /pubmed/37389368 http://dx.doi.org/10.3389/fnins.2023.1067098 Text en Copyright © 2023 Faber, Ballegaard, Ørsted, Eldrup, Karpatschof, Gyntelberg, Hecquet and Gjedde. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Faber, Jens
Ballegaard, Søren
Ørsted, Nanna
Eldrup, Ebbe
Karpatschof, Benny
Gyntelberg, Finn
Hecquet, Sofie Korsgaard
Gjedde, Albert
In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
title In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
title_full In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
title_fullStr In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
title_full_unstemmed In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
title_short In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
title_sort in type 2 diabetes mellitus, normalization of hemoglobin a1c accompanies reduced sensitivity to pressure at the sternum
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303981/
https://www.ncbi.nlm.nih.gov/pubmed/37389368
http://dx.doi.org/10.3389/fnins.2023.1067098
work_keys_str_mv AT faberjens intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT ballegaardsøren intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT ørstednanna intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT eldrupebbe intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT karpatschofbenny intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT gyntelbergfinn intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT hecquetsofiekorsgaard intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum
AT gjeddealbert intype2diabetesmellitusnormalizationofhemoglobina1caccompaniesreducedsensitivitytopressureatthesternum